Junhye Kwon

1.0k total citations
31 papers, 854 citations indexed

About

Junhye Kwon is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Junhye Kwon has authored 31 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Junhye Kwon's work include MicroRNA in disease regulation (4 papers), Cancer Cells and Metastasis (3 papers) and Ubiquitin and proteasome pathways (3 papers). Junhye Kwon is often cited by papers focused on MicroRNA in disease regulation (4 papers), Cancer Cells and Metastasis (3 papers) and Ubiquitin and proteasome pathways (3 papers). Junhye Kwon collaborates with scholars based in South Korea, United States and Sweden. Junhye Kwon's co-authors include Moon Chul Kang, Enfeng Wang, Resham Bhattacharya, Priyabrata Mukherjee, Sujata Patra, Debabrata Mukhopadhyay, Ui Sup Shin, Jong Ho Park, Hyun Jung Cho and Hongtae Kim and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Junhye Kwon

31 papers receiving 850 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junhye Kwon South Korea 18 594 274 205 99 93 31 854
Gvantsa Kharaishvili Czechia 18 404 0.7× 347 1.3× 221 1.1× 107 1.1× 153 1.6× 26 776
Paraskevi Alexandrou Greece 18 497 0.8× 390 1.4× 280 1.4× 72 0.7× 82 0.9× 43 922
Yukinao Kouzu Japan 18 541 0.9× 250 0.9× 189 0.9× 146 1.5× 109 1.2× 28 795
Christopher M. Raskett United States 13 718 1.2× 236 0.9× 173 0.8× 129 1.3× 110 1.2× 25 992
Wensheng Qiu China 17 518 0.9× 215 0.8× 271 1.3× 69 0.7× 162 1.7× 71 842
Keiichi Aomatsu Japan 15 510 0.9× 254 0.9× 194 0.9× 70 0.7× 96 1.0× 23 817
Mazvita Maziveyi United States 7 588 1.0× 261 1.0× 280 1.4× 90 0.9× 89 1.0× 9 858
Dawid G. Nowak United States 12 952 1.6× 167 0.6× 242 1.2× 64 0.6× 133 1.4× 20 1.2k
Kathy A. Toy United States 17 666 1.1× 358 1.3× 340 1.7× 51 0.5× 85 0.9× 19 999
Hans Petter Eikesdal Norway 19 496 0.8× 412 1.5× 292 1.4× 49 0.5× 106 1.1× 41 987

Countries citing papers authored by Junhye Kwon

Since Specialization
Citations

This map shows the geographic impact of Junhye Kwon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhye Kwon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhye Kwon more than expected).

Fields of papers citing papers by Junhye Kwon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junhye Kwon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhye Kwon. The network helps show where Junhye Kwon may publish in the future.

Co-authorship network of co-authors of Junhye Kwon

This figure shows the co-authorship network connecting the top 25 collaborators of Junhye Kwon. A scholar is included among the top collaborators of Junhye Kwon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junhye Kwon. Junhye Kwon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Jae Yeon, Dong Hyeon Lee, Junhye Kwon, et al.. (2024). miR-1226-5p is involved in radioresistance of colorectal cancer by activating M2 macrophages through suppressing IRF1. Journal of Translational Medicine. 22(1). 980–980. 4 indexed citations
2.
Kwon, Junhye, et al.. (2023). Fisetin induces the upregulation of AKAP12 mRNA and anti-angiogenesis in a patient-derived organoid xenograft model. Biomedicine & Pharmacotherapy. 167. 115613–115613. 8 indexed citations
3.
Kwon, Junhye, et al.. (2020). Butyrate enhances the efficacy of radiotherapy via FOXO3A in colorectal cancer patient‑derived organoids. International Journal of Oncology. 57(6). 1307–1318. 60 indexed citations
4.
Lee, Yeon‐Joo, Jae-Min Cho, Sei Sai, et al.. (2019). 5-Fluorouracil as a Tumor-Treating Field-Sensitizer in Colon Cancer Therapy. Cancers. 11(12). 1999–1999. 30 indexed citations
5.
Park, Misun, et al.. (2017). Abstract 5858: MicroRNA-338-5p regulates radioresistance by directly targeting survivin in esophageal squamous cell carcinoma. Cancer Research. 77(13_Supplement). 5858–5858. 1 indexed citations
6.
Kang, Moon Chul, et al.. (2017). MiR-338-5p enhances the radiosensitivity of esophageal squamous cell carcinoma by inducing apoptosis through targeting survivin. Scientific Reports. 7(1). 10932–10932. 46 indexed citations
7.
Choi, Jungil, Eung‐Ho Cho, Sang Bum Kim, et al.. (2017). Promoter methylation of cysteine dioxygenase type 1: gene silencing and tumorigenesis in hepatocellular carcinoma. Annals of Hepato-Biliary-Pancreatic Surgery. 21(4). 181–181. 10 indexed citations
8.
Kang, Moon Chul, et al.. (2016). PTK7 regulates radioresistance through nuclear factor-kappa B in esophageal squamous cell carcinoma. Tumor Biology. 37(10). 14217–14224. 19 indexed citations
9.
Kwon, Junhye, et al.. (2015). Epigenetic regulation of the novel tumor suppressor cysteine dioxygenase 1 in esophageal squamous cell carcinoma. Tumor Biology. 36(10). 7449–7456. 14 indexed citations
10.
Kim, Jihee, et al.. (2014). Protein tyrosine kinase 7 plays a tumor suppressor role by inhibiting ERK and AKT phosphorylation in lung cancer. Oncology Reports. 31(6). 2708–2712. 30 indexed citations
11.
Kwon, Junhye, Ji‐Hee Kim, Tae Sup Lee, et al.. (2014). Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma. Oncology Reports. 32(3). 1188–1192. 10 indexed citations
12.
Kwon, Junhye, et al.. (2014). Specificity Protein 1 Expression Contributes to Bcl-w-Induced Aggressiveness in Glioblastoma Multiforme. Molecules and Cells. 37(1). 17–23. 17 indexed citations
13.
Kim, Chang Hee, Hae‐Seong Nam, Eun Hee Lee, et al.. (2013). Overexpression of a novel regulator of p120 catenin, NLBP, promotes lung adenocarcinoma proliferation. Cell Cycle. 12(15). 2443–2453. 24 indexed citations
14.
Shin, Won‐Sik, et al.. (2013). Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma. Cancer Science. 104(8). 1120–1126. 55 indexed citations
15.
Kwon, Junhye, et al.. (2013). Integrin alpha 6: A novel therapeutic target in esophageal squamous cell carcinoma. International Journal of Oncology. 43(5). 1523–1530. 36 indexed citations
16.
Kwon, Junhye, et al.. (2013). Bcl-w Enhances Mesenchymal Changes and Invasiveness of Glioblastoma Cells by Inducing Nuclear Accumulation of β-Catenin. PLoS ONE. 8(6). e68030–e68030. 24 indexed citations
17.
Cho, Hyun Jung, et al.. (2010). c-Myc Stimulates Cell Invasion by Inhibiting FBX8 Function. Molecules and Cells. 30(4). 355–362. 15 indexed citations
18.
Kwon, Junhye, et al.. (2010). A Novel LZAP-binding Protein, NLBP, Inhibits Cell Invasion. Journal of Biological Chemistry. 285(16). 12232–12240. 51 indexed citations
20.
Bhattacharya, Resham, Junhye Kwon, Enfeng Wang, et al.. (2008). Role of Hedgehog Signaling in Ovarian Cancer. Clinical Cancer Research. 14(23). 7659–7666. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026